查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434998

爱迪生氏症症药物市场：按药物类别、诊断、治疗方法、分销管道、给药途径分类 - 全球预测 2024-2030

Addison's Disease Treatment Market by Drug Class (Glucocorticoid, Mineralocorticoid), Diagnosis (Imaging Testing, Laboratory Testing), Treatments, Distribution Channel, Route of Administration - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

爱迪生氏症治疗市场规模预计2023年为14.1亿美元，预计2024年将达到15.4亿美元，2030年将达到28.8亿美元，复合年增长率为10.72%。

爱迪生氏症病药物的全球市场

主要市场统计
基准年[2023] 14.1亿美元
预测年份 [2024] 15.4亿美元
预测年份 [2030] 28.8亿美元
复合年增长率（%） 10.72%
艾迪生氏症治疗药物Market-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估爱迪生氏症药物市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对爱迪生氏症治疗药物市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-爱迪生氏症治疗药物市场的市场规模和预测是多少？

2-在爱迪生氏症治疗药物市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-爱迪生氏症治疗药物市场的技术趋势和法律规范是什么？

4-爱迪生氏症治疗药物市场主要供应商的市场占有率是多少？

5-进入爱迪生氏症药物市场的适当型态或策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球爱迪生氏症率增加
      • 人们对肾上腺功能不全的认知不断增强
      • 实施强大的医疗基础设施和有利的报销政策
    • 抑制因素
      • 艾迪生治疗相关的高成本
    • 机会
      • 对新一代技术整合先进疗法的需求不断增长
      • 增加研发活动并提高公司对开发爱迪生氏症治疗方法的关注
    • 任务
      • 人们对爱迪生氏症缺乏认识
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章依药物类别分類的爱迪生氏症治疗药物市场

  • 糖皮质素
    • 地塞米松
    • Hydrocortisone
    • 强的松
  • 盐皮质激素
    • ludrocortisone

第七章 依诊断分类的爱迪生氏症治疗药物市场

  • 影像检查
  • 临床检查

第八章爱迪生氏症治疗药物市场（依治疗）

  • 皮质类固醇注射
  • 自然疗法解决方案
  • 口服类固醇

第九章爱迪生氏症治疗药物市场：按分销管道

  • 电子商务
  • 医院药房
  • 零售药房

第 10 章爱迪生氏症治疗药物市场：依给药途径

  • 口服
  • 家长

第十一章 美洲爱迪生氏症生病药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区爱迪生氏症治疗药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲爱迪生氏症症药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第15章竞争组合

  • 主要公司简介
    • Abbott Laboratories
    • Actiza Pharmaceutical Private Limited
    • Akorn Operating Company LLC
    • Amgen Inc.
    • Amneal Pharmaceuticals, Inc.
    • Bay Biosciences LLC
    • Bayer AG
    • Bio-Techne Corporation
    • Biogen Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • BTL Biotechno Labs Pvt Ltd.
    • Cardinal Health, Inc.
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Hikma Pharmaceuticals PLC
    • LUMITOS AG
    • Lupin Limited
    • Merck KGaA
    • Neurocrine Biosciences, Inc.
    • Novartis AG
    • Pfizer Inc.
    • Recipharm AB
    • Sandoz International GmbH
    • Takeda Pharmaceutical Company Limited
  • 主要产品系列

第十六章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-B16853776F22

[195 Pages Report] The Addison's Disease Treatment Market size was estimated at USD 1.41 billion in 2023 and expected to reach USD 1.54 billion in 2024, at a CAGR 10.72% to reach USD 2.88 billion by 2030.

Global Addison's Disease Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.41 billion
Estimated Year [2024] USD 1.54 billion
Forecast Year [2030] USD 2.88 billion
CAGR (%) 10.72%
Addison's Disease Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Addison's Disease Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Addison's Disease Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Addison's Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Actiza Pharmaceutical Private Limited, Akorn Operating Company LLC, Amgen Inc., Amneal Pharmaceuticals, Inc., Bay Biosciences LLC, Bayer AG, Bio-Techne Corporation, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, BTL Biotechno Labs Pvt Ltd., Cardinal Health, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, LUMITOS AG, Lupin Limited, Merck KGaA, Neurocrine Biosciences, Inc., Novartis AG, Pfizer Inc., Recipharm AB, Sandoz International GmbH, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Addison's Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Glucocorticoid
      • Dexamethasone
      • Hydrocortisone
      • Prednisone
    • Mineralocorticoid
      • Fludrocortisone
  • Diagnosis
    • Imaging Testing
    • Laboratory Testing
  • Treatments
    • Corticosteroid Injections
    • Naturopathic Solutions
    • Oral Corticosteroids
  • Distribution Channel
    • E-Commerce
    • Hospital Pharmacy
    • Retail Pharmacy
  • Route of Administration
    • Oral
    • Parental
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Addison's Disease Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Addison's Disease Treatment Market?

3. What are the technology trends and regulatory frameworks in the Addison's Disease Treatment Market?

4. What is the market share of the leading vendors in the Addison's Disease Treatment Market?

5. Which modes and strategic moves are suitable for entering the Addison's Disease Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Addison's Disease Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of Addison's disease globally
      • 5.1.1.2. Growing awareness regarding adrenal insufficiency
      • 5.1.1.3. Inception of robust healthcare infrastructure and favorable reimbursement policies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with the Addison treatment medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for new generation technologically integrated advanced therapeutic drugs
      • 5.1.3.2. Increasing R&D activities and rising focus of the companies in developing treatments for Addison's disease
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness among people regarding Addison's disease
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Addison's Disease Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Glucocorticoid
    • 6.3.1. Dexamethasone
    • 6.3.2. Hydrocortisone
    • 6.3.3. Prednisone
  • 6.3. Mineralocorticoid
    • 6.4.1. Fludrocortisone

7. Addison's Disease Treatment Market, by Diagnosis

  • 7.1. Introduction
  • 7.2. Imaging Testing
  • 7.3. Laboratory Testing

8. Addison's Disease Treatment Market, by Treatments

  • 8.1. Introduction
  • 8.2. Corticosteroid Injections
  • 8.3. Naturopathic Solutions
  • 8.4. Oral Corticosteroids

9. Addison's Disease Treatment Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. E-Commerce
  • 9.3. Hospital Pharmacy
  • 9.4. Retail Pharmacy

10. Addison's Disease Treatment Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Oral
  • 10.3. Parental

11. Americas Addison's Disease Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Addison's Disease Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Addison's Disease Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Abbott Laboratories
    • 15.1.2. Actiza Pharmaceutical Private Limited
    • 15.1.3. Akorn Operating Company LLC
    • 15.1.4. Amgen Inc.
    • 15.1.5. Amneal Pharmaceuticals, Inc.
    • 15.1.6. Bay Biosciences LLC
    • 15.1.7. Bayer AG
    • 15.1.8. Bio-Techne Corporation
    • 15.1.9. Biogen Inc.
    • 15.1.10. Boehringer Ingelheim International GmbH
    • 15.1.11. Bristol-Myers Squibb Company
    • 15.1.12. BTL Biotechno Labs Pvt Ltd.
    • 15.1.13. Cardinal Health, Inc.
    • 15.1.14. Eli Lilly and Company
    • 15.1.15. GlaxoSmithKline PLC
    • 15.1.16. Hikma Pharmaceuticals PLC
    • 15.1.17. LUMITOS AG
    • 15.1.18. Lupin Limited
    • 15.1.19. Merck KGaA
    • 15.1.20. Neurocrine Biosciences, Inc.
    • 15.1.21. Novartis AG
    • 15.1.22. Pfizer Inc.
    • 15.1.23. Recipharm AB
    • 15.1.24. Sandoz International GmbH
    • 15.1.25. Takeda Pharmaceutical Company Limited
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ADDISON'S DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ADDISON'S DISEASE TREATMENT MARKET DYNAMICS
  • FIGURE 7. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 8. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 10. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2030 (%)
  • FIGURE 12. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 16. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ADDISON'S DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. ADDISON'S DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ADDISON'S DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ADDISON'S DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 6. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 8. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 13. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY FLUDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 15. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY IMAGING TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 18. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY NATUROPATHIC SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ORAL CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ADDISON'S DISEASE TREATMENT MARKET SIZE, BY PARENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 158. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 172. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 173. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 174. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 180. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 181. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 187. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 188. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 194. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 195. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 201. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 202. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 208. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 209. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 215. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 216. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 222. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 223. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 229. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 230. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 236. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 237. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 243. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 244. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 249. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 250. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 251. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 256. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 257. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 258. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 263. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 264. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 278. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 279. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 284. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 285. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 286. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 291. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 292. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 293. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 294. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 298. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 299. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 300. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 301. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 305. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 306. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 307. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY TREATMENTS, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES ADDISON'S DISEASE TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED KINGDOM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED KINGDOM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY GLUCOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED KINGDOM ADDISON'S DISEASE TREATMENT MARKET SIZE, BY MINERALOCORTICOID, 2018-2030 (USD MILLION)
  • TABLE 315. UNI